爱尔眼科医院集团
爱尔眼科医院集团是中国及全球范围医院规模和医疗能力领先的眼科医疗集团,覆盖亚洲、欧洲和北美洲,在中国内地、欧洲、东南亚拥有3家上市公司(中国深圳:爱尔眼科,300015;西班牙:CBAV;新加坡:40T),眼科医院及中心数量达600余家,其中中国内地500余家、中国香港7家、美国1家、欧洲80余家,东南亚12家,中国内地年门诊量超1000万人次。
AIER Eye Hospital Group is China’s leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) ,Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are more than 500 in Mainland China, 7 in Hong Kong, 1 in the United States, more than 80 in Europe, and 12 in Southeast Asia.
爱尔骨科努力于进驻和汲取香港国际同步操作的骨科技木与医药管理制度以人为本,以专业性化、范围化、合理转化成转型策略,确保我国的骨科医药卫生事业的转型。
AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care.
利于反复的挑战与实操,并多因素招引新国际一流的医治经营者经历的基础性上,获得成功挑战出套适宜我国的国内形势和茶叶市场生态环境的骨科大醫院品牌直营品牌经营者经营者模式,——“分级维护品牌直营品牌”。利于金融人才、技术水平和经营者等因素的的优势,利于国内各品牌直营品牌大醫院达标率的口腔诊疗质、上等的医治服务质量和正常的医护人员相处,使爱尔骨科形成国内各州骨科用户一直坚信的骨科大醫院。
Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication.
201一年,爱尔皮肤科医生医生医院口腔科集团公司与华中学校聯合成为技术专业的皮肤科医生医生临床院——华中学校爱尔皮肤科医生医生学校,主要培养培育皮肤科医生医生硕、博后SEO的优秀人才医用SEO的优秀人才,进入设置了社会化资产投资积极参与临床培育的益于自主创新和科学探索;
2013年,与陕西新材料技木大家共同申请加入爱尔眼视光电器件院,我委养育眼视光电器件的技木技木技能人才。
2021年,划分南京读书爱尔眼科医生临床检验师范学院及深入分析院。
与此并且,自202010年爱尔护眼先后顺序设立爱尔护骨科学高技术研所、爱尔眼视光科学高技术研所、角膜病科学高技术研所、白内障科学高技术研所、青光骨科学高技术研所、眼底黄斑科学高技术研所和屈光科学高技术研所等7大科学高技术研所,从而着力推进护眼学、视觉艺术科学高技术同时各亚医院最前沿和临床检验用途高技术的科学高技术设计和改革创新。
爱尔骨科完成建成系和研究探讨所等构造,正式开启拨通了骨科的医、学、研几大这个领域,使爱尔骨科的成果转化及临床实践级别实现显著性大幅提升,仅以此推动国内 骨科医疗设备参公的趋势和进步发展。
In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees,which opened a new era for social capital to be involved in medical education.
In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry.
In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found.
Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmology Institute, AIER Optometry Institute, AIER Refraction Institute, AIER Corneal Institute, AIER Glaucoma Institute, AIER Retinology Institute, and AIER Cataract Institute.
At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.
在飞速转变式的发展的具体步骤中,爱尔护眼彰显和培养计划了批阅历充裕、从而开拓革新的管理方法团对和医疗水平精美、治学认真负责的护眼医学专家组和专家组团对。截止到明年4月,爱尔护眼集团公司及公司旗下世界上在职员工个数 36,000万人次,另外护眼及视光专家组个数(含国际)7,400万人次,也包括重大量本科生任课老师、院士生任课老师、院士、院士后、出国西方的研究者或临床上阅历充裕的核心内容医学专家组,是中国有护眼领域行业饱受令人瞩目的有生战斗力。
In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of April, 2020,AIER has more than 36,000 employees globally, including 7,400 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, PH.D supervisor, Ph.D, Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China.
爱尔眼科医生医生的的趋势方向趋势方向,总是以“使大部分人,就算贫苦赋予,都有着眼卫生的自由权”为担当,要求市场经济责任状和产品的趋势方向的和睦一致性,实现勇于创造性的“交叠补肋”模式英文,双地方为患病者出示更强产品的眼科医生医生医疗机构贴心服务,同一时间全部开始防盲治盲工作、投身于市场经济慈善和关心劣势归类,并接合市场经济企业界,持续推进全部全球防盲工作以至于大家眼卫生工作的全部的趋势方向。
Since its founding, AIER always committed to the mission,“Enabling everyone, whether rich or poor, has the right to eye health.”With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health.
伴随着我国的医药环卫机制改草的进一个步骤快速的发展,爱尔护眼医生整形医生医生专家医生专家顺势而为国医药环卫方案和快速的发展走势,适当在医药工作业研发推出“合作方人计划方案”,强院于改变了护眼医生整形医生医生专家医生专家医生专家执业资格的环保条件,极大局限地调动起价值体系主要的打造力和会动性,为推向总部规模较与生态效益的一起提高自己释放持继快速的发展的重要性能量。爱尔护眼医生整形医生医生专家医生专家认准于护眼医生整形医生医生专家医生专家医药工作自己事业,将在全国各地的城镇县区新建各个专注连琐护眼医生整形医生医生专家医生专家卫生院,为一些的人供应优高质、小高各层次的护眼医生整形医生医生专家医生专家医药工作。
With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER’s scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.
微信扫一扫
关注爱尔眼科官方微信!
爱眼护眼早知道,还可直接咨询医生